QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VII — PSUR Scope, Objectives and Regulatory Purpose

Test your understanding of the concepts covered by GVP Module VII: PSUR Scope, Objectives and Regulatory Purpose.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Reports of a known adverse reaction doubled during a reporting period. Exposure also doubled, and case characteristics remained consistent with the established risk. Which interpretation is most defensible?

The incidence necessarily doubled because the number of reports doubled The increased reporting may be explained partly by increased exposure and does not alone demonstrate a material increase in risk The reaction should automatically be classified as a new safety signal The increase should be ignored because the reaction was already known

Question 2 of 10 A potential serious safety issue is identified shortly before the PSUR data lock point and may require urgent regulatory action. What is the most appropriate approach?

Defer all assessment until the next PSUR is submitted Exclude the issue because it was identified too close to the data lock point Use the applicable immediate safety, signal-management or regulatory pathway and address it in the PSUR as appropriate Include the issue only if it has already become a validated signal

Question 3 of 10 Why is a PSUR not adequately characterised as an ICSR compilation?

ICSRs are not relevant to periodic safety evaluation ICSRs may only be reviewed in clinical trials and not in post-authorisation settings The regulatory value of the evidence depends on clinical interpretation, integration with other sources and conclusions about benefit-risk ICSRs are used only for safety communication and not for regulatory assessment

Question 4 of 10 Why is avoiding double counting important when integrating PSUR data?

Duplicate records can falsely inflate the apparent amount or strength of evidence Each source must be analysed in isolation and never reconciled Double counting affects only administrative workload and not scientific conclusions Duplicate records are required to demonstrate consistency across databases

Question 5 of 10 How should signal management generally interface with PSUR preparation?

The PSUR should create a separate signal-management system for all signals Only closed signals may be mentioned in a PSUR The PSUR should use controlled signal-management outputs and evaluate their implications in the broader safety and benefit-risk context Signal management is unnecessary once a PSUR has been submitted

Question 6 of 10 Which outcome may legitimately follow from a PSUR assessment?

Only continuation of the existing product information is possible The report must always result in product withdrawal if a new observation is identified Possible outcomes include no change, further monitoring, additional studies, changes to risk minimisation or product information, or other regulatory action The PSUR itself automatically implements every required regulatory measure

Question 7 of 10 What is the primary operational significance of the data lock point?

It is only the date on which the final report must be signed It establishes the controlled point at which the principal reporting dataset is closed for the defined period It marks the end of all signal-management activities It determines whether the benefit-risk balance is positive

Question 8 of 10 Which statement best reflects the role of clinical-study information in a PSUR?

Study data are always more reliable than spontaneous reports and require no contextual interpretation Study data may provide controlled populations and denominators, but their applicability may be limited by population, duration, size or ability to detect rare events Study data are outside PSUR scope unless they identify a validated signal Clinical-study information should be reproduced in full whenever a study exists

Question 9 of 10 What is the most appropriate distinction between information that is new during the reporting interval and cumulative knowledge?

Only information first received during the interval is scientifically relevant Previously known information should never appear in a PSUR The report should distinguish newly available information from prior knowledge while evaluating how the totality of evidence changes understanding Cumulative knowledge refers only to cases received in the immediately preceding interval

Question 10 of 10 Which factor is least consistent with a scientifically supported benefit-risk conclusion?

The seriousness and clinical consequences of the risk The magnitude and relevance of the therapeutic benefit The strength and limitations of the available evidence A predetermined conclusion that the benefit-risk balance remains positive

Knowledge Assessment: GVP Module VII — PSUR Scope, Objectives and Regulatory Purpose

Cookie Settings